Navigation

Breast cancer (advanced and/or metastatic) - sunitinib (in combination with capecitabine) [ID319]

Sunitinib in combination with capecitabine within its licensed indication for the treatment of advanced and/or metastatic breast cancer

Status: Suspended
Expected date of issue: TBC
Referral date: March 2009
Process: STA
Notes:

Cancer reform strategy Batch 5

Topic area:
 

NICE project team

Executive Lead: TBC
Technical Lead: TBC
Communications manager: TBC
Project manager: TBC
Assessment Group / Evidence Review Group: TBC
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: TBC
1st appraisal committee meeting: TBC
2nd appraisal committee meeting TBC
Top


 

Consultees and commentators

To be confirmed

Top


 

Project history

Date Update
5 April 2010 The manufacturer of sunitinib has advised us that regulatory approval for this technology is not being sought at this time following the receipt of trial data. The Institute has therefore decided to remove this appraisal from its current work programme. As this topic has been referred to the Institute we will continue to monitor any development and will update interested parties if the situation changes. If you have any comments or concerns please do not hesitate to contact the Project Manager for this appraisal, Cathryn Hall (020 7045 2240 or email: (cathryn.hall@nice.org.uk).
23 September 2009 Please note that following on from advice received from the manufacturer, this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, we now anticipate that the appraisal will begin during mid November 2010. The deadline for submissions is expected in approximately early February 2011.
Top


 

Key documents

This page was last updated: 02 July 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.